Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. | Nat Commun | 2023 | 37644036 | PubTator, text mining | PubMed |
| Genetic enhancers of partial PLK1 inhibition reveal hypersensitivity to kinetochore perturbations. | PLoS Genet | 2023 | 37639469 | PubTator, text mining | PubMed |
| Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study. | Lancet Diabetes Endocrinol | 2023 | 37619579 | PubTator, text mining | PubMed |
| Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition. | Proc Natl Acad Sci U S A | 2023 | 37603740 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers. | Front Oncol | 2023 | 37601657 | PubTator, text mining | PubMed |
| Proliferation-Related Features of the Human Mesenchymal Stem Cells Derived from Palatine Tonsils, Adipose Tissues, and Bone Marrow. | Tissue Eng Regen Med | 2023 | 37594634 | PubTator, text mining | PubMed |
| Knockdown of BUB1 inhibits tumor necrosis factor-α-induced proliferation and migration of rheumatoid arthritis synovial fibroblasts by regulating PI3K/Akt pathway. | Int J Rheum Dis | 2023 | 37593912 | PubTator, text mining | PubMed |
| CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor. | BMC Med Genomics | 2023 | 37592341 | PubTator, text mining | PubMed |
| Ret deficiency decreases neural crest progenitor proliferation and restricts fate potential during enteric nervous system development. | Proc Natl Acad Sci U S A | 2023 | 37585461 | PubTator, text mining | PubMed |
| Identification of functional genes regulating gastric cancer progression using integrated bioinformatics analysis. | World J Clin Cases | 2023 | 37583848 | PubTator, text mining | PubMed |
| Predicting the impact of sequence motifs on gene regulation using single-cell data. | Genome Biol | 2023 | 37582793 | PubTator, text mining | PubMed |
| Higher Sensitivity to Thyroid Hormones May Be Linked to Maintaining the Healthy Metabolic Condition in People with Obesity: New Insight from NHANES. | Obes Facts | 2023 | 37573776 | PubTator, text mining | PubMed |
| Role of microRNAs in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2023 | 37569845 | PubTator, text mining | PubMed |
| p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer. | Cell Death Dis | 2023 | 37553320 | PubTator, text mining | PubMed |
| Identification of distinct gene co-expression modules and specific hub genes in skin lesions of atopic dermatitis and psoriasis by WGCNA. | FEBS Open Bio | 2023 | 37548115 | PubTator, text mining | PubMed |
| Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer. | Funct Integr Genomics | 2023 | 37542643 | PubTator, text mining | PubMed |
| Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment. | Front Cell Dev Biol | 2023 | 37538397 | PubTator, text mining | PubMed |
| System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma. | PLoS One | 2023 | 37535572 | PubTator, text mining | PubMed |
| In Silico Insight to Identify Potential Inhibitors of BUB1B from Mushroom Bioactive Compounds to Prevent Breast Cancer Metastasis. | Front Biosci (Landmark Ed) | 2023 | 37525917 | PubTator, text mining | PubMed |
| Low tension recruits the yeast Aurora B protein Ipl1 to centromeres in metaphase. | J Cell Sci | 2023 | 37519149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=16